Skip to main content
Comment ClosedFDA· Food and Drug AdministrationProposed RuleFDA-2025-N-5995

Effective Date of Requirement for Premarket Approval Applications for Blood Irradiators Intended To Prevent Metastasis

Introduced March 18, 2026Comment period ends May 19, 2026View on regulations.gov ↗

What This Means

This regulation appears to establish a premarket approval process for blood irradiation devices intended to prevent metastasis. The rule would affect medical device manufacturers and clinical applications.

Plain language summary generated by AI · Civitics

Community Position

Community Comments

Other Open FDA Proposals

Comment Period

The public comment period for this proposal has closed.

Details

TypeFederal Regulation
AgencyFDA · Food and Drug Administration
DocketFDA-2025-N-5995
Regulations.gov IDFDA-2025-N-5995-0001
IntroducedMarch 18, 2026
Comment DeadlineMay 19, 2026